Sukhjit Kaur, - Medicare Nurse Practitioner in Modesto, CA

Sukhjit Kaur, is a medicare enrolled "Nurse Practitioner - Family" in Modesto, California. Her current practice location is 801 17th St, Modesto, California. You can reach out to her office (for appointments etc.) via phone at (209) 251-0200.

Sukhjit Kaur is licensed to practice in California (license number 95018150) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1023780244.

Contact Information

Sukhjit Kaur,
801 17th St,
Modesto, CA 95354-1243
(209) 251-0200
Not Available



Provider's Profile

Full NameSukhjit Kaur
GenderFemale
SpecialityNurse Practitioner - Family
Location801 17th St, Modesto, California
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1023780244
  • Provider Enumeration Date: 10/05/2021
  • Last Update Date: 10/05/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 8921482183
  • Enrollment ID: I20220907002255

Medical Identifiers

Medical identifiers for Sukhjit Kaur such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1023780244NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
363LF0000XNurse Practitioner - Family 95018150 (California)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sukhjit Kaur allows following entities to bill medicare on her behalf.
Entity NameAlexander Y Chan, Md Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1831360809
PECOS PAC ID: 7517044811
Enrollment ID: O20080410000798

News Archive

New inhibitor of SARS-CoV-2 RNA translation

As the search for effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibitors continues, a recent study by Yale University School of Medicine researchers published on the preprint server bioRxiv in October 2020 reports the inhibitory effect of the drug merofloxacin on frameshifting during SARS-CoV-2 replication.

Subdominant SARS-CoV-2 epitopes key to understanding emerging variants

Researchers in the UK have conducted a study showing the importance of considering subdominant epitopes within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when investigating neutralizing antibodies that target the virus.

TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

TechniScan, Inc., the developer of a revolutionary 3-D breast imaging system, announced today the grant of U.S. Patent 7,684,846, which provides additional intellectual property protection for proprietary methods in creating diagnostic images from complex wave fields.

Research journal to host a webinar on apoptotic signalling in normal and cancer cell biology

The business office of Science, the world's leading peer-reviewed research journal, is producing a webinar on "Apoptotic Signaling in Normal and Cancer Cell Biology" to be broadcast live online at 12 noon ET (4:00 GMT) September 22, 2009, sponsored by Promega.

Read more Medical News

› Verified 7 days ago

Entity NameGaps Health Ca
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1184283608
PECOS PAC ID: 2668702481
Enrollment ID: O20190920002704

News Archive

New inhibitor of SARS-CoV-2 RNA translation

As the search for effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibitors continues, a recent study by Yale University School of Medicine researchers published on the preprint server bioRxiv in October 2020 reports the inhibitory effect of the drug merofloxacin on frameshifting during SARS-CoV-2 replication.

Subdominant SARS-CoV-2 epitopes key to understanding emerging variants

Researchers in the UK have conducted a study showing the importance of considering subdominant epitopes within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when investigating neutralizing antibodies that target the virus.

TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

TechniScan, Inc., the developer of a revolutionary 3-D breast imaging system, announced today the grant of U.S. Patent 7,684,846, which provides additional intellectual property protection for proprietary methods in creating diagnostic images from complex wave fields.

Research journal to host a webinar on apoptotic signalling in normal and cancer cell biology

The business office of Science, the world's leading peer-reviewed research journal, is producing a webinar on "Apoptotic Signaling in Normal and Cancer Cell Biology" to be broadcast live online at 12 noon ET (4:00 GMT) September 22, 2009, sponsored by Promega.

Read more Medical News

› Verified 7 days ago

Entity NameMismo Dermatology Group Apc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1306405998
PECOS PAC ID: 7012247414
Enrollment ID: O20190927001616

News Archive

New inhibitor of SARS-CoV-2 RNA translation

As the search for effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibitors continues, a recent study by Yale University School of Medicine researchers published on the preprint server bioRxiv in October 2020 reports the inhibitory effect of the drug merofloxacin on frameshifting during SARS-CoV-2 replication.

Subdominant SARS-CoV-2 epitopes key to understanding emerging variants

Researchers in the UK have conducted a study showing the importance of considering subdominant epitopes within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when investigating neutralizing antibodies that target the virus.

TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

TechniScan, Inc., the developer of a revolutionary 3-D breast imaging system, announced today the grant of U.S. Patent 7,684,846, which provides additional intellectual property protection for proprietary methods in creating diagnostic images from complex wave fields.

Research journal to host a webinar on apoptotic signalling in normal and cancer cell biology

The business office of Science, the world's leading peer-reviewed research journal, is producing a webinar on "Apoptotic Signaling in Normal and Cancer Cell Biology" to be broadcast live online at 12 noon ET (4:00 GMT) September 22, 2009, sponsored by Promega.

Read more Medical News

› Verified 7 days ago

Entity NameCareconnectmd Ca Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1366063125
PECOS PAC ID: 5496178055
Enrollment ID: O20200715000596

News Archive

New inhibitor of SARS-CoV-2 RNA translation

As the search for effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibitors continues, a recent study by Yale University School of Medicine researchers published on the preprint server bioRxiv in October 2020 reports the inhibitory effect of the drug merofloxacin on frameshifting during SARS-CoV-2 replication.

Subdominant SARS-CoV-2 epitopes key to understanding emerging variants

Researchers in the UK have conducted a study showing the importance of considering subdominant epitopes within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when investigating neutralizing antibodies that target the virus.

TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

TechniScan, Inc., the developer of a revolutionary 3-D breast imaging system, announced today the grant of U.S. Patent 7,684,846, which provides additional intellectual property protection for proprietary methods in creating diagnostic images from complex wave fields.

Research journal to host a webinar on apoptotic signalling in normal and cancer cell biology

The business office of Science, the world's leading peer-reviewed research journal, is producing a webinar on "Apoptotic Signaling in Normal and Cancer Cell Biology" to be broadcast live online at 12 noon ET (4:00 GMT) September 22, 2009, sponsored by Promega.

Read more Medical News

› Verified 7 days ago

Entity NameS&p Nursing Corp
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1720850837
PECOS PAC ID: 1557718780
Enrollment ID: O20231109002987

News Archive

New inhibitor of SARS-CoV-2 RNA translation

As the search for effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibitors continues, a recent study by Yale University School of Medicine researchers published on the preprint server bioRxiv in October 2020 reports the inhibitory effect of the drug merofloxacin on frameshifting during SARS-CoV-2 replication.

Subdominant SARS-CoV-2 epitopes key to understanding emerging variants

Researchers in the UK have conducted a study showing the importance of considering subdominant epitopes within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when investigating neutralizing antibodies that target the virus.

TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

TechniScan, Inc., the developer of a revolutionary 3-D breast imaging system, announced today the grant of U.S. Patent 7,684,846, which provides additional intellectual property protection for proprietary methods in creating diagnostic images from complex wave fields.

Research journal to host a webinar on apoptotic signalling in normal and cancer cell biology

The business office of Science, the world's leading peer-reviewed research journal, is producing a webinar on "Apoptotic Signaling in Normal and Cancer Cell Biology" to be broadcast live online at 12 noon ET (4:00 GMT) September 22, 2009, sponsored by Promega.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sukhjit Kaur is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sukhjit Kaur,
915 Chastanet Ct,
Livingston, CA 95334-9237

Ph: (209) 535-4693
Sukhjit Kaur,
801 17th St,
Modesto, CA 95354-1243

Ph: (209) 251-0200

News Archive

New inhibitor of SARS-CoV-2 RNA translation

As the search for effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibitors continues, a recent study by Yale University School of Medicine researchers published on the preprint server bioRxiv in October 2020 reports the inhibitory effect of the drug merofloxacin on frameshifting during SARS-CoV-2 replication.

Subdominant SARS-CoV-2 epitopes key to understanding emerging variants

Researchers in the UK have conducted a study showing the importance of considering subdominant epitopes within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when investigating neutralizing antibodies that target the virus.

TechniScan granted U.S. patent for methods in creating diagnostic images from complex wave fields

TechniScan, Inc., the developer of a revolutionary 3-D breast imaging system, announced today the grant of U.S. Patent 7,684,846, which provides additional intellectual property protection for proprietary methods in creating diagnostic images from complex wave fields.

Research journal to host a webinar on apoptotic signalling in normal and cancer cell biology

The business office of Science, the world's leading peer-reviewed research journal, is producing a webinar on "Apoptotic Signaling in Normal and Cancer Cell Biology" to be broadcast live online at 12 noon ET (4:00 GMT) September 22, 2009, sponsored by Promega.

Read more News

› Verified 7 days ago


Nurse Practitioner Nurses in Modesto, CA

Anissa Brown,
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 1700 Standiford Ave, Modesto, CA 95350
Phone: 209-676-3069    
Nameeta Heer,
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 1316 Celeste Dr, Modesto, CA 95355
Phone: 209-571-1055    
Mrs. Lois Elaine Lewis, RN NURSE PRACTITIONE
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 205 W Granger Ave, Modesto, CA 95350
Phone: 209-579-9930    Fax: 209-579-9941
Ms. Margaret Baker, FNPC
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 1448 Florida Ave, Modesto, CA 95350
Phone: 209-523-1884    Fax: 209-523-2566
Ms. Fantine Warda, NP
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 1700 Coffee Rd, Modesto, CA 95355
Phone: 209-526-4500    Fax: 209-572-7901
Ms. Tracy Lynne Bondi, NP
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 600 Coffee Rd, Modesto, CA 95355
Phone: 209-524-1211    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.